United States · FDA National Drug Code directory
Ramelteon
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70700-272_15d4da7a-2091-e84d-872c-57ef7141d813
- Product NDC
- 70700-272
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ramelteon
- Labeler
- Xiromed, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221125
- Source listing expiry
- 20261231
Source-listed ingredients
- RAMELTEON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (70700-272-05) · 70700-272-05
- 100 TABLET, FILM COATED in 1 BOTTLE (70700-272-10) · 70700-272-10
- 30 TABLET, FILM COATED in 1 BOTTLE (70700-272-30) · 70700-272-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →